Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Severe hypertriglyceridaemia and chylomicronaemia syndrome—causes, clinical presentation, and therapeutic options

B Bashir, JH Ho, P Downie, P Hamilton, G Ferns… - Metabolites, 2023 - mdpi.com
We have reviewed the genetic basis of chylomicronaemia, the difference between
monogenic and polygenic hypertriglyceridaemia, its effects on pancreatic, cardiovascular …

The role of apheresis and insulin therapy in hypertriglyceridemic acute pancreatitis—a concise review

J Gubensek - BMC gastroenterology, 2023 - Springer
Severe hypertriglyceridemia (HTG) is the third most common cause of acute pancreatitis
(AP) and is involved in its pathogenesis. Chylomicrons increase blood viscosity and induce …

Early plasmapheresis among patients with hypertriglyceridemia–associated acute pancreatitis

L Cao, Y Chen, S Liu, W Huang, D Wu… - JAMA Network …, 2023 - jamanetwork.com
Importance The incidence of hypertriglyceridemia–associated acute pancreatitis (HTG-AP)
is increasing. Plasmapheresis is theoretically effective in removing triglyceride from plasma …

Medical management of hypertriglyceridemia in pancreatitis

N Gligorijevic, M Stefanovic-Racic… - Current Opinion in …, 2023 - journals.lww.com
Medical management of hypertriglyceridemia in pancreatitis : Current Opinion in
Gastroenterology Medical management of hypertriglyceridemia in pancreatitis : Current …

Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine …

RA Metcalf, CS Cohn, S Bakhtary, T Gniadek… - …, 2023 - Wiley Online Library
Abstract Background The Association for the Advancement of Blood and Biotherapies
Clinical Transfusion Medicine Committee (CTMC) composes a summary of new and …

Therapeutic plasma exchange in ICU patients with acute hypertriglyceridemia-induced pancreatitis improves patient outcomes

LU Krauß, AM Brosig, S Schlosser, V Pavel… - Digestive …, 2023 - karger.com
Background: Acute severe pancreatitis is associated with high morbidity and mortality.
Hypertriglyceridemia is the third most common cause of acute pancreatitis and higher …

Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis

L Wang, J Zhou, C Lv, D Hong, Z Wang, W Mao… - Annals of Intensive …, 2024 - Springer
Background Plasmapheresis is widely used for severe hypertriglyceridemia-associated
acute pancreatitis (HTG-AP) to remove excessive triglycerides from plasma. This study …

Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia

B Bashir, M Ferdousi, P Durrington… - Current Opinion in …, 2024 - journals.lww.com
Despite advancements in understanding the genetic basis and pathogenesis of SHTG,
diagnostic and therapeutic challenges persist. The rarity of FCS and the heterogenous …

Long-chain fatty acids-The turning point between 'mild'and 'severe'acute pancreatitis

Q Liu, X Gu, X Liu, Y Gu, H Zhang, J Yang, Z Huang - Heliyon, 2024 - cell.com
Acute pancreatitis (AP) is an inflammatory disease characterized by localized pancreatic
injury and a systemic inflammatory response. Fatty acids (FAs), produced during the …